Migrapest-Forte Tablet SR is a combination medicine containing Propranolol (40mg) and Flunarizine (10mg) in a sustained release formulation. It is indicated for the prophylactic treatment of migraine and other vascular headaches. The product combines the beta-blocking properties of Propranolol, which helps to reduce the frequency and severity of migraine attacks, with the calcium-channel-blocking properties of Flunarizine, which reduces the transmission of pain signals to the brain. The sustained release formulation ensures a steady and prolonged release of the active ingredients, providing a consistent therapeutic effect over an extended period. Migrapest-Forte Tablet SR is particularly useful for patients who experience frequent or severe migraine episodes, as it helps to prevent the onset of attacks and reduce the need for rescue medications. The product is contraindicated in patients with known hypersensitivity to Propranolol or Flunarizine, as well as in those with certain cardiac conditions, and should be used with caution in patients with a history of depression or anxiety.